Entrada Therapeutics, Inc. · NASDAQ:TRDA

Wentworth Kory James sold 2,500 Entrada Therapeutics, Inc. shares (Form 4)

Traded Apr 1, 2026 · Filed Apr 2, 2026

On Apr 1, 2026, Wentworth Kory James (Chief Financial Officer) sold 2,500 Entrada Therapeutics, Inc. shares at US$12.95 for US$32,375 under a trading plan, leaving 119,010 shares. Filed Apr 2, 2026 (Form 4).

Sold
2,500 shares
Price
US$12.95
Value
US$32,375
Holding after
119,010 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 1, 2026Common StockSale2,500US$12.95119,010Direct

Source

View original at SEC

Related